(Q28277361)

English

Urinary tract antiseptics

scientific article

In more languages

Statements

scholarly article

0 references

1 reference

Europe PubMed Central

Urinary tract antiseptics (English)

0 references

0 references

author name string

A R Mayrer

1

0 references

V T Andriole

2

0 references

language of work or name

0 references

publication date

January 1982

0 references

Medical Clinics of North America

0 references

66

0 references

199-208

0 references

1

0 references

Plasma Levels and Urinary Excretion of Nalidixic Acid in Patients with Renal Failure*

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931453-5

7 January 2021

Nalidixic acid and oxolinic acid in the treatment of chronic bacteriuria.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931453-5

7 January 2021

Hepatic reaction to nitrofurantoin

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931453-5

7 January 2021

Studies on the mechanism of action of nalidixic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931453-5

7 January 2021

Intracranial Hypertension and Papilledema Associated by Nalidixic Acid Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931453-5

7 January 2021

Some antibacterial properties of mandelamine (methenamine mandelate)

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931453-5

7 January 2021

Neural, hematologic and bacteriologic effects of nitrofurantoin in renal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931453-5

7 January 2021

Long-term therapy for chronic bacteriuria in men. U.S. Public Health Service cooperative study

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931453-5

7 January 2021

The Prolonged Use of Methenamine Hippurate in the Treatment of Chronic Urinary Tract Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931453-5

7 January 2021

A Controlled Study of Antimicrobial Prophylaxis of Recurrent Urinary Infection in Women

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931453-5

7 January 2021

Crystalline and Macrocrystalline Nitrofurantoin in the Treatment of Urinary-Tract Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931453-5

7 January 2021

1,8-Naphthyridine Derivatives. A New Class of Chemotherapeutic Agents

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931453-5

7 January 2021

Haemolytic crisis produced by nalidixic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931453-5

7 January 2021

ABSORPTION, EXCRETION, AND METABOLISM OF A NEW ANTIBACTERIAL AGENT, NALIDIXIC ACID

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931453-5

7 January 2021

Pulmonary reactions simulating cardiac pulmonary edema caused by nitrofurantoin

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931453-5

7 January 2021

A Critical Evaluation of Nalidixic Acid in Urinary-Tract Infections

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931453-5

7 January 2021

Effect of renal function on urinary recovery of orally administered nitrofurantoin

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931453-5

7 January 2021

Recurrent urinary tract infections in men. Characteristics and response to therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931453-5

7 January 2021

Prophylactic efficacy of nitrofurantoin macrocrystals and trimethoprim-sulfamethoxazole in urinary infections. Biologic effects on the vaginal and rectal flora

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931453-5

7 January 2021

Antimicrobial prophylaxis of recurrent urinary tract infections: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931453-5

7 January 2021

Is antimicrobial prophylaxis of urinary tract infections cost effective?

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931453-5

7 January 2021

Nitrofurantoin polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931453-5

7 January 2021

Lack of effect of methenamine in suppression of, or prophylaxis against, chronic urinary infection

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931453-5

7 January 2021

Letter: Antagonism of oxolinic acid by nitrofurantoin

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2931453-5

7 January 2021

Identifiers

10.1016/S0025-7125(16)31453-5

0 references

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28277361&oldid=1623488213"